0,848  0,004  Respiratory analeptic
0,779  0,005  Analeptic
0,759  0,004  NOS3 expression inhibitor
0,739  0,005  CTGF expression inhibitor
0,720  0,003  Antiemetic
0,676  0,002  Dopamine transporter inhibitor
0,668  0,005  Cardiodepressant
0,666  0,005  Dependence treatment
0,674  0,020  CYP3A4 substrate
0,663  0,011  Antiparkinsonian
0,666  0,015  CYP2C9 substrate
0,650  0,002  5 Hydroxytryptamine uptake stimulant
0,649  0,003  Pneumotoxic
0,663  0,017  TNF expression inhibitor
0,645  0,004  5 Hydroxytryptamine uptake inhibitor
0,623  0,004  Alpha-N-acetylglucosaminidase inhibitor
0,627  0,012  Cognition disorders treatment
0,618  0,004  Anesthetic general
0,621  0,011  Spasmolytic
0,619  0,016  Mood disorders treatment
0,605  0,016  Antidepressant
0,594  0,006  Psychostimulant
0,598  0,013  CYP2D6 substrate
0,569  0,005  Antimigraine
0,565  0,012  Ulceration
0,582  0,030  Analgesic
0,553  0,003  Adrenaline uptake inhibitor
0,579  0,039  Caspase 9 stimulant
0,556  0,019  Antipsychotic
0,548  0,012  FMO1 substrate
0,563  0,029  GST A substrate
0,543  0,021  5 Hydroxytryptamine release stimulant
0,506  0,004  Antiparkinsonian, tremor relieving
0,508  0,007  Flavin-containing monooxygenase substrate
0,514  0,021  Immunomodulator
0,497  0,005  Abortion inducer
0,510  0,020  Hepatic disorders treatment
0,505  0,027  CYP2C19 substrate
0,469  0,006  FMO3 substrate
0,483  0,024  Sensitization
0,490  0,032  Embryotoxic
0,465  0,010  UGT1A4 substrate
0,489  0,036  Antipruritic, allergic
0,458  0,007  Irritable Bowel syndrome treatment
0,464  0,013  Interleukin 2 agonist
0,482  0,034  Teratogen
0,439  0,005  Acetylcholine M1 receptor antagonist
0,468  0,037  Aldehyde oxidase inhibitor
0,444  0,016  Radiosensitizer
0,428  0,007  Cholinergic antagonist
0,442  0,021  UGT2B4 substrate
0,421  0,007  Acetylcholine antagonist
0,447  0,035  Anxiolytic
0,416  0,005  Cocaine dependence treatment
0,431  0,023  HERG channel blocker
0,418  0,012  Antiparkinsonian, rigidity relieving
0,416  0,011  Anesthetic
0,408  0,026  Potassium channel (Voltage-sensitive) blocker
0,396  0,022  DNA synthesis inhibitor
0,428  0,054  Immunosuppressant
0,390  0,020  Interleukin agonist
0,419  0,054  Antiasthmatic
0,361  0,005  Acetylcholine muscarinic antagonist
0,372  0,017  GST M1-1 substrate
0,390  0,042  Radioprotector
0,373  0,027  Sodium/bile acid cotransporter inhibitor
0,361  0,016  UGT2B7 substrate
0,348  0,005  Opioid kappa receptor antagonist
0,344  0,007  UGT2B9 substrate
0,372  0,041  UGT1A9 substrate
0,382  0,053  Cholesterol antagonist
0,370  0,043  CYP2D6 inhibitor
0,342  0,017  Prostatic (benign) hyperplasia treatment
0,325  0,004  Dopamine uptake inhibitor
0,324  0,006  Acetylcholine nicotinic antagonist
0,382  0,067  Toll-Like receptor 7 agonist
0,334  0,020  Tyrosine 3 hydroxylase inhibitor
0,368  0,055  Antifungal
0,351  0,039  Antihypoxic
0,319  0,008  Aldehyde oxidase substrate
0,345  0,035  Antineoplastic (liver cancer)
0,380  0,071  GABA C receptor rho-3 antagonist
0,376  0,070  Toll-Like receptor agonist
0,352  0,049  Metabolic disease treatment
0,310  0,009  Antitussive
0,319  0,019  5 Hydroxytryptamine 1E antagonist
0,323  0,026  Eye irritation, high
0,308  0,012  Anesthetic local
0,316  0,020  Peptidyltransferase inhibitor
0,323  0,031  UDP-glucuronosyltransferase substrate
0,376  0,085  Analgesic, non-opioid
0,346  0,058  Antipsoriatic
0,293  0,006  Antineoplastic, alkylator
0,334  0,048  Chemoprotective
0,329  0,044  Chronic obstructive pulmonary disease treatment
0,322  0,039  UGT1A6 substrate
0,290  0,010  Bronchodilator
0,300  0,024  Antialcoholic
0,306  0,030  RNA-directed DNA polymerase inhibitor
0,281  0,006  Constipation treatment
0,277  0,004  Prokinetic
0,347  0,075  Vasodilator, peripheral
0,317  0,046  Cardiovascular analeptic
0,332  0,062  Calcium channel activator
0,277  0,008  UGT2B10 substrate
0,377  0,109  Alzheimer's disease treatment
0,274  0,007  VEGF expression inhibitor
0,269  0,004  Acetylcholine muscarinic agonist
0,269  0,006  Opioid antagonist
0,283  0,021  Prostate disorders treatment
0,273  0,011  Neuropathy treatment
0,280  0,018  Antidote
0,285  0,024  Antiviral (Hepatitis)
0,319  0,058  Antineoplastic (small cell lung cancer)
0,273  0,012  Sulfotransferase substrate
0,294  0,034  Sedative
0,308  0,050  Cytotoxic
0,308  0,053  Cardiotonic
0,300  0,046  Potassium channel blocker
0,288  0,035  UGT1A1 substrate
0,259  0,008  Acetylcholine agonist
0,351  0,102  Antibacterial
0,297  0,050  Angiogenesis stimulant
0,317  0,074  Immunostimulant
0,260  0,018  Antidiarrheal
0,247  0,005  Acetylcholine M3 receptor antagonist
0,257  0,016  Carcinogenic, group 1
0,244  0,004  Peristaltic stimulant
0,245  0,006  Neuronal nicotinic receptor antagonist
0,304  0,066  CYP1A2 substrate
0,251  0,013  ATPase inhibitor
0,271  0,034  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,257  0,021  Antiviral (Hepatitis C)
0,255  0,019  Toxic, respiratory center
0,279  0,044  Antiarrhythmic
0,259  0,025  UGT2B15 substrate
0,238  0,004  Antihypermotility
0,239  0,006  Creatine kinase inhibitor
0,235  0,003  Narcotic antagonist
0,244  0,013  Antismoking
0,262  0,031  Antipruritic, non-allergic
0,247  0,017  Uterine stimulant
0,286  0,056  Superoxide dismutase inhibitor
0,244  0,013  Expectorant
0,256  0,027  Hair growth stimulant
0,235  0,006  Antineoplastic alkaloid
0,235  0,007  5 Hydroxytryptamine 3A agonist
0,231  0,004  Acetylcholine M1 receptor agonist
0,251  0,029  Skeletal muscle relaxant
0,262  0,040  Muscle relaxant
0,241  0,020  Adenylate cyclase inhibitor
0,223  0,004  Glycine receptor agonist
0,308  0,090  Transcription factor NF kappa B inhibitor
0,219  0,001  Antidote, organophosphates
0,293  0,076  Antineoplastic (ovarian cancer)
0,277  0,061  Proliferative diseases treatment
0,230  0,014  Antirickettsial
0,232  0,019  Alkylator
0,222  0,009  Mucolytic
0,244  0,032  UGT1A3 substrate
0,217  0,006  Acetylcholine M2 receptor antagonist
0,222  0,012  Movement disorders treatment
0,218  0,009  Hearing loss treatment
0,212  0,007  Prolactin inhibitor
0,221  0,017  GABA C receptor agonist
0,295  0,091  Vasodilator, coronary
0,265  0,061  Cytostatic
0,200  0,003  Alpha-mannosidase inhibitor
0,267  0,072  DNA damaging
0,204  0,008  Opioid mu receptor antagonist
0,198  0,004  Ca2+-transporting ATPase inhibitor
0,218  0,024  Cell wall synthesis inhibitor
0,197  0,004  Nicotinic alpha4beta2 receptor antagonist
0,209  0,017  UDP-glucose 4-epimerase inhibitor
0,209  0,018  Antiviral (Poxvirus)
0,221  0,032  Acute respiratory distress syndrome (ARDS) treatment
0,198  0,010  Sphingomyelinase inhibitor
0,222  0,034  Protein kinase stimulant
0,246  0,058  Antihypotensive
0,196  0,011  Triose-phosphate isomerase inhibitor
0,257  0,072  Gastrin inhibitor
0,263  0,080  Renal disease treatment
0,217  0,035  Interferon gamma antagonist
0,193  0,012  Chronic obstructive bronchitis treatment
0,219  0,037  Liver fibrosis treatment
0,246  0,066  Cyclic AMP phosphodiesterase inhibitor
0,184  0,005  Acetylcholine release stimulant
0,187  0,007  Alcohol oxidase inhibitor
0,205  0,029  Arachidonic acid antagonist
0,232  0,058  Antiviral (West Nile virus)
0,176  0,003  Nicotinic alpha3beta2 receptor antagonist
0,218  0,046  Lipocortins synthesis antagonist
0,175  0,005  Nicotinic receptor alpha7 subunit antagonist
0,218  0,048  Antimutagenic
0,190  0,019  Choleretic
0,286  0,117  Antineoplastic (non-Hodgkin's lymphoma)
0,295  0,126  Histamine release inhibitor
0,242  0,072  Antiglaucomic
0,215  0,047  Diabetic nephropathy treatment
0,207  0,039  Phospholipase C inhibitor
0,290  0,123  Antiobesity
0,250  0,084  Amyotrophic lateral sclerosis treatment
0,192  0,026  Cystathionine beta-synthase inhibitor
0,182  0,016  Antispirochetal
0,173  0,008  UGT2B11 substrate
0,179  0,015  Antiviral (Influenza B)
0,168  0,004  Acetylcholine M5 receptor agonist
0,172  0,007  5 Hydroxytryptamine 3 antagonist
0,209  0,046  Antiviral (Ebola)
0,165  0,004  Mannosidase inhibitor
0,165  0,004  Nicotinic receptor alpha4 subunit antagonist
0,179  0,019  Pregnane X receptor agonist
0,204  0,045  Cholinergic
0,239  0,080  Tumour necrosis factor alpha release inhibitor
0,216  0,057  Sigma receptor agonist
0,173  0,015  Opioid delta receptor antagonist
0,170  0,012  Analgesic, opioid
0,204  0,046  Antipruritic
0,220  0,063  Carcinogenic
0,177  0,020  UGT2B1 substrate
0,261  0,105  Antineoplastic (osteosarcoma)
0,267  0,111  ICAM1 expression inhibitor
0,181  0,025  Adenylate cyclase stimulant
0,162  0,007  Androgen agonist
0,261  0,107  CYP3A4 inhibitor
0,221  0,067  VCAM1 expression inhibitor
0,196  0,043  Antineoplastic (squamous cell carcinoma)
0,178  0,024  SULT1A1 substrate
0,179  0,026  Excitatory amino acid transporter EAAC1 inhibitor
0,163  0,010  Carbamoyl phosphate synthetase inhibitor
0,188  0,036  SULT1A3 substrate
0,172  0,020  Adenylate kinase inhibitor
0,173  0,021  Protein kinase C gamma inhibitor
0,177  0,025  Liver cirrhosis treatment
0,158  0,007  Tourette's syndrome treatment
0,201  0,050  Antihelmintic (Nematodes)
0,198  0,048  Cytidine deaminase inhibitor
0,215  0,066  Nitric-oxide synthase stimulant
0,264  0,115  Antithrombotic
0,272  0,123  Inflammatory Bowel disease treatment
0,211  0,063  DNA methyltransferase I inhibitor
0,159  0,011  Antidote, mercury
0,163  0,016  Phosphofructokinase-1 inhibitor
0,177  0,030  GST P1-1 substrate
0,169  0,023  Gastritis treatment
0,155  0,010  Acetylcholine M4 receptor antagonist
0,172  0,028  Microtubule formation inhibitor
0,173  0,029  Ferrochelatase inhibitor
0,159  0,015  NADH dehydrogenase inhibitor
0,251  0,108  Nootropic
0,209  0,068  Neurotrophic factor enhancer
0,214  0,073  MAP kinase kinase 2 inhibitor
0,245  0,105  Hypoxia-inducible factor 1 alpha inhibitor
0,225  0,085  NOS2 expression inhibitor
0,323  0,184  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,186  0,047  Attention deficit/hyperactivity disorder treatment
0,143  0,005  Antiviral (Parainfluenza)
0,161  0,023  DNA repair enzyme inhibitor
0,154  0,016  Acetylcholine nicotinic agonist
0,154  0,016  Anabolic
0,210  0,073  DNA methylase inhibitor
0,156  0,020  Carcinogenic, group 2A
0,250  0,113  Bone diseases treatment
0,161  0,026  Heat shock protein 70 antagonist
0,187  0,053  Antiviral (Herpes)
0,179  0,044  Antinephritic
0,151  0,017  GST T1-1 substrate
0,151  0,019  Acetylcholine M3 receptor agonist
0,168  0,037  Antiviral (Hepatitis B)
0,177  0,047  Genotoxic
0,184  0,054  Acaricide
0,138  0,009  Acetylcholine M5 receptor antagonist
0,135  0,007  Nicotinic receptor alpha3 subunit antagonist
0,170  0,044  Neurotrophic factor
0,133  0,007  5 Hydroxytryptamine 3A antagonist
0,129  0,005  Nicotinic receptor beta4 subunit antagonist
0,142  0,018  SULT1E1 substrate
0,130  0,009  Anticholelithogenic
0,136  0,015  Dyspepsia treatment
0,158  0,038  Autism spectrum disorders treatment
0,290  0,172  Antidiabetic
0,290  0,172  Cyclophilin D inhibitor
0,228  0,110  Cardioprotectant
0,122  0,004  Vesicle monoamine transporter inhibitor
0,119  0,002  Vesicular acetylcholine transporter inhibitor
0,225  0,108  Antineurogenic pain
0,120  0,005  Sphingosine kinase 2 inhibitor
0,123  0,007  Antimycoplasmal
0,140  0,025  Androgen antagonist
0,128  0,014  Glycine receptor antagonist
0,117  0,004  SULT2A1 substrate
0,300  0,187  Antineoplastic (solid tumors)
0,152  0,039  Antineoplastic antimetabolite
0,291  0,179  Apoptosis agonist
0,210  0,097  Vasodilator
0,183  0,071  LDLR expression enhancer
0,158  0,046  5 Hydroxytryptamine antagonist
0,130  0,020  Glutamate dehydrogenase inhibitor
0,185  0,075  Hepatoprotectant
0,161  0,051  Antifungal enhancer
0,126  0,016  ATPase (Vacuolar H+) inhibitor
0,146  0,037  Contraceptive female
0,139  0,030  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,142  0,034  Anticataract
0,114  0,007  Gaucher disease treatment
0,115  0,008  Protein kinase C beta inhibitor
0,115  0,008  Dopamine D5 antagonist
0,115  0,010  5 Hydroxytryptamine 3 agonist
0,110  0,005  Anesthetic inhalation
0,139  0,034  Antineoplastic antibiotic
0,129  0,024  Antibiotic
0,250  0,145  Antineoplastic (breast cancer)
0,121  0,017  mTOR complex 2 inhibitor
0,263  0,160  CYP2C19 inhibitor
0,108  0,005  5 Hydroxytryptamine 4 antagonist
0,146  0,044  Growth stimulant
0,181  0,079  P-glycoprotein inhibitor
0,183  0,082  CYP2B6 inhibitor
0,126  0,025  Lanosterol 14 alpha demethylase inhibitor
0,112  0,011  Opioid agonist
0,114  0,014  Acyl-CoA dehydrogenase inhibitor
0,124  0,024  mTOR complex 1 inhibitor
0,163  0,064  Antiviral (Influenza A)
0,137  0,038  GABA C receptor antagonist
0,104  0,009  Opioid kappa receptor agonist
0,101  0,005  Andropause treatment
0,143  0,048  Cholesterol synthesis inhibitor
0,098  0,004  Acetylcholine M4 receptor agonist
0,110  0,017  Argininosuccinate synthase inhibitor
0,207  0,114  Antiprotozoal (Trypanosoma)
0,169  0,076  Phobic disorders treatment
0,181  0,087  Antiviral (Influenza)
0,171  0,078  Succinate dehydrogenase inhibitor
0,113  0,021  Na+ K+ transporting ATPase inhibitor
0,280  0,188  5 Hydroxytryptamine release inhibitor
0,102  0,011  MAP kinase kinase 7 inhibitor
0,132  0,042  Alpha 2c adrenoreceptor antagonist
0,156  0,067  Raynaud's phenomenon treatment
0,097  0,009  Sphingosine kinase inhibitor
0,099  0,011  Cyclin-dependent kinase 6 inhibitor
0,106  0,018  Estrogen-related receptor beta agonist
0,099  0,011  Glutamate (mGluR7) antagonist
0,118  0,032  Paget's disease treatment
0,158  0,072  Cyclin-dependent kinase 8 inhibitor
0,149  0,064  Amylase inhibitor
0,147  0,063  Antiacne
0,164  0,080  Mutagenic
0,156  0,073  Diuretic
0,299  0,216  Antiinflammatory
0,102  0,020  Sleep apnea treatment
0,091  0,010  Glucosylceramidase inhibitor
0,109  0,029  Histidine decarboxylase inhibitor
0,110  0,030  Tocolytic
0,095  0,015  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,117  0,038  Electrolyte absorption antagonist
0,115  0,036  Protein kinase C zeta inhibitor
0,130  0,051  Alpha 2b adrenoreceptor antagonist
0,082  0,003  Nicotinic alpha3beta4 receptor agonist
0,084  0,006  5 Hydroxytryptamine 3B antagonist
0,096  0,018  Protein kinase C eta inhibitor
0,118  0,041  GABA C receptor rho-1 antagonist
0,083  0,008  Glucose-6-phosphate isomerase inhibitor
0,240  0,164  Antineoplastic (endocrine cancer)
0,108  0,034  Bile acid receptor antagonist
0,086  0,011  5-Alpha-reductase inhibitor
0,146  0,071  Antiprotozoal (Coccidial)
0,204  0,130  Antidiabetic (type 2)
0,088  0,014  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,079  0,005  Farnesoid X receptor agonist
0,091  0,018  Uterine relaxant
0,082  0,009  Prolactin release inhibitor
0,186  0,114  Antihypercholesterolemic
0,217  0,145  AR expression inhibitor
0,097  0,026  Dopamine D1 antagonist
0,102  0,033  Antiprotozoal activity enhancer
0,151  0,082  Urinary incontinence treatment
0,090  0,022  Biliverdin reductase inhibitor
0,166  0,099  Non-steroidal antiinflammatory agent
0,107  0,040  Phosphodiesterase 6D inhibitor
0,095  0,029  CC chemokine 5 receptor agonist
0,089  0,023  Phospholipase D inhibitor
0,083  0,017  Antihemophilic
0,083  0,018  Protein 50S ribosomal subunit inhibitor
0,133  0,068  Antiprotozoal (Trichomonas)
0,090  0,026  Vanilloid 4 agonist
0,067  0,004  Ceramide glucosyltransferase inhibitor
0,095  0,032  Antiviral (Dengue virus)
0,146  0,084  CF transmembrane conductance regulator agonist
0,100  0,039  Antileprosy
0,072  0,011  Adenylate cyclase 1 inhibitor
0,067  0,006  Guanylate cyclase inhibitor
0,081  0,020  Nicotinic neuronal receptor agonist
0,168  0,109  Anticonvulsant
0,201  0,141  Prostate cancer treatment
0,118  0,059  GABA receptor agonist
0,121  0,062  Antifungal (Pneumocystis)
0,083  0,025  Narcolepsy treatment
0,158  0,100  Antihelmintic
0,073  0,015  Antiviral (Herpesvirus 3, Human)
0,120  0,063  Antiprotozoal (Babesia)
0,169  0,112  Antiparasitic
0,193  0,137  Antineoplastic (sarcoma)
0,143  0,087  Hexokinase inhibitor
0,101  0,045  Actinic keratosis treatment
0,143  0,087  Aldose reductase substrate
0,079  0,025  Glutamate (mGluR6) antagonist
0,099  0,045  Glutamate release inhibitor
0,075  0,022  Sigma receptor antagonist
0,069  0,015  Pregnane X receptor antagonist
0,088  0,035  Aminopeptidase I inhibitor
0,126  0,073  Retinoprotector
0,112  0,060  Falcipain 3 inhibitor
0,062  0,010  Parathyroid hormone antagonist
0,117  0,065  Interleukin 8 antagonist
0,089  0,037  Glutamate decarboxylase inhibitor
0,061  0,011  Dopamine D5 agonist
0,062  0,013  Thymidine kinase inhibitor
0,068  0,019  Potassium channel (Inward rectifier) blocker
0,059  0,011  Arginase inhibitor
0,118  0,070  DNA polymerase I inhibitor
0,103  0,054  Glutamate (mGluR7) agonist
0,075  0,028  MDM2 inhibitor
0,110  0,064  Vasculitis treatment
0,094  0,048  Bromodomain-containing protein 2 inhibitor
0,094  0,049  Gastroesophageal reflux disease treatment
0,095  0,051  Histamine N-methyltransferase inhibitor
0,052  0,007  Tubulin agonist
0,091  0,048  Arylamine N-Acetyltransferase substrate
0,096  0,053  Antithrombocytopenic
0,084  0,040  SULT1A2 substrate
0,066  0,023  Acetylcholine M2 receptor agonist
0,055  0,012  Sphingosine kinase 1 inhibitor
0,087  0,044  Somatostatin 1 agonist
0,047  0,006  Nociceptin (N/OFQ) receptor agonist
0,070  0,028  Cyclin D1 inhibitor
0,142  0,101  Muscular dystrophy treatment
0,044  0,004  Hedgehog signaling activator
0,130  0,090  Peroxidase inhibitor
0,089  0,050  Antiviral (Trachoma)
0,060  0,021  Adenosine deaminase inhibitor
0,067  0,027  Ornithine carbamoyltransferase inhibitor
0,168  0,129  Urologic disorders treatment
0,065  0,027  Nicotinic alpha7 receptor agonist
0,122  0,083  Contraceptive
0,103  0,065  NAT2 substrate
0,165  0,128  Antineoplastic (lymphoma)
0,046  0,009  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,120  0,083  CNS active muscle relaxant
0,050  0,014  Kainate receptor agonist
0,134  0,098  GABA C receptor rho-2 antagonist
0,042  0,006  Purinergic P2Y15 antagonist
0,120  0,085  Antihemorrhagic
0,042  0,007  Nicotinic alpha4beta2 receptor agonist
0,058  0,023  HCV NS3/NS4A protease inhibitor
0,039  0,004  1,3-Beta-glucan synthase inhibitor
0,130  0,095  Chemopreventive
0,048  0,014  Fumarate hydratase inhibitor
0,050  0,016  Hypogonadism treatment
0,058  0,024  Phosphodiesterase 7A inhibitor
0,068  0,035  Antidote, heavy metal
0,101  0,067  Glutathione S-transferase substrate
0,117  0,083  Antihyperlipoproteinemic
0,125  0,092  Farnesoid X receptor antagonist
0,136  0,103  Melanin inhibitor
0,047  0,014  Glutamate (mGluR3) antagonist
0,077  0,045  5 Hydroxytryptamine 1F antagonist
0,046  0,015  Antihyperaldosteronism
0,115  0,083  Cyclooxygenase 3 inhibitor
0,089  0,057  Contraceptive male
0,070  0,039  Hyperparathyroidism treatment
0,084  0,053  Histamine H1 receptor antagonist
0,087  0,056  Sodium/hydrogen exchanger 5 inhibitor
0,122  0,091  Lipid peroxidase inhibitor
0,090  0,059  Phosphodiesterase I inhibitor
0,077  0,047  Adenosine A3 receptor antagonist
0,039  0,010  Protein kinase C beta I inhibitor
0,085  0,055  GABA A receptor agonist
0,091  0,061  Restless leg syndrome treatment
0,108  0,079  Carcinogenic, group 3
0,056  0,026  Topoisomerase II beta inhibitor
0,076  0,046  Potassium channel (Tandem pore domain) blocker
0,092  0,062  Antihistaminic
0,062  0,033  Lipocortins synthesis agonist
0,062  0,033  Ryanodine receptor antagonist
0,065  0,037  Purinergic P2X1 antagonist
0,033  0,005  5 Hydroxytryptamine 4 agonist
0,044  0,015  RNA-directed RNA polymerase stimulant
0,106  0,078  Photosensitizer
0,059  0,031  Melanin-concentrating hormone receptor 1 antagonist
0,035  0,007  Thymidine kinase (Herpes simplex virus 1) inhibitor
0,041  0,014  HMG CoA reductase inhibitor
0,087  0,060  Interleukin-1 receptor-associated protein kinase 4 inhibitor
0,105  0,078  5 Hydroxytryptamine 2B antagonist
0,085  0,059  Hematopoietic
0,060  0,034  Postcoital contraceptive
0,031  0,005  Antibiotic Quinolone-like
0,076  0,051  Antitreponemal
0,044  0,019  Cholesterol absorption inhibitor
0,052  0,027  Opioid mu receptor agonist
0,067  0,042  Hypercalcemia treatment
0,047  0,022  Nerve growth factor antagonist
0,057  0,033  Lysine-specific demethylase 1A inhibitor
0,042  0,019  Glucose-6-phosphate dehydrogenase inhibitor
0,118  0,096  Antineoplastic (carcinoma)
0,073  0,051  Dopamine antagonist
0,061  0,039  Adenosine A1 receptor antagonist
0,061  0,040  Phosphodiesterase 1A inhibitor
0,034  0,013  Potassium channel (Inward rectifier) 1 blocker
0,041  0,020  Antiviral (Bovine viral diarrhea virus)
0,073  0,052  S-adenosyl-L-methionine decarboxylase inhibitor
0,107  0,087  Shock treatment
0,104  0,084  Myasthenia Gravis treatment
0,025  0,005  Antibiotic Anthracycline-like
0,032  0,012  Estrogen-related receptor gamma antagonist
0,037  0,018  Adenosine uptake inhibitor
0,073  0,054  Cushing's syndrome treatment
0,082  0,063  Alpha 2 adrenoreceptor antagonist
0,097  0,078  Antihelmintic (Fasciola)
0,034  0,015  Sigma 2 receptor antagonist
0,039  0,020  Opioid delta receptor agonist
0,046  0,028  AICAR transformylase inhibitor
0,124  0,106  Heat shock protein 90 antagonist
0,127  0,108  Antifungal (Cryptococcus)
0,027  0,010  5-Alpha-reductase 2 inhibitor
0,031  0,014  HCV NS5A inhibitor
0,095  0,078  Toll-Like receptor 4 antagonist
0,039  0,022  Antibiotic Aminoglycoside-like
0,031  0,014  LFA antagonist
0,040  0,023  Glutamate (mGluR8) agonist
0,037  0,020  Sodium-dependent vitamin C transporter 2 inhibitor
0,028  0,012  Vanilloid 2 agonist
0,022  0,006  Telomerase stimulant
0,107  0,091  Alcohol dehydrogenase substrate
0,179  0,163  Antiepileptic
0,095  0,079  Antiprotozoal (Toxoplasma)
0,123  0,108  Hemostatic
0,052  0,036  Aconitate hydratase inhibitor
0,048  0,032  Aldosterone antagonist
0,022  0,006  NMDA receptor phencyclidine site antagonist
0,020  0,005  Thromboxane A2 agonist
0,169  0,153  Antiosteoporotic
0,024  0,009  Thymidine kinase (Herpes simplex virus 2) inhibitor
0,034  0,019  Vanilloid 4 antagonist
0,097  0,082  DOPA decarboxylase inhibitor
0,065  0,051  Phenylalanine 4-hydroxylase inhibitor
0,088  0,074  Aminopeptidase B inhibitor
0,020  0,006  Purinergic P2Y1 agonist
0,165  0,152  5 Hydroxytryptamine 3E antagonist
0,060  0,046  Phosphodiesterase VII inhibitor
0,043  0,029  Oxytocin agonist
0,084  0,072  HIV-1 integrase (Overall Integration) inhibitor
0,125  0,113  Growth hormone agonist
0,024  0,012  Isoleucine-tRNA ligase inhibitor
0,045  0,033  Premature ejaculation treatment
0,078  0,066  Histamine antagonist
0,037  0,025  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,111  0,100  Antihelmintic (Trematoda)
0,023  0,013  Vitamin D receptor antagonist
0,106  0,095  Toll-Like receptor 2 antagonist
0,030  0,021  Dipeptidyl peptidase I inhibitor
0,165  0,157  Lipoprotein disorders treatment
0,048  0,040  Antiviral (Hepatitis D)
0,027  0,020  Hypoxanthine phosphoribosyltransferase inhibitor
0,036  0,028  Delayed rectifier potassium channel blocker
0,056  0,049  Dopamine D3 antagonist
0,074  0,067  MAP kinase 7 inhibitor
0,019  0,011  Methylmalonyl-CoA mutase inhibitor
0,022  0,015  GRP78 expression inhibitor
0,085  0,078  MAP kinase kinase 1 inhibitor
0,103  0,096  Mental retardation treatment
0,044  0,037  Antibiotic Glycopeptide-like
0,041  0,034  GABA B receptor antagonist
0,085  0,079  Antiviral (Hepatitis A)
0,014  0,008  Cyclin D2 inhibitor
0,018  0,012  5-Alpha-reductase 1 inhibitor
0,125  0,119  MAP kinase 3 inhibitor
0,109  0,103  Toll-Like receptor antagonist
0,057  0,051  Dopamine D2 antagonist
0,022  0,016  Prostaglandin F2 alpha agonist
0,067  0,062  Alpha 2a adrenoreceptor antagonist
0,052  0,046  5 Hydroxytryptamine 6 antagonist
0,183  0,178  Ca2+/calmodulin-dependent kinase II alpha inhibitor
0,036  0,031  Vascular adhesion protein 1 inhibitor
0,032  0,028  Phosphoglycerate kinase inhibitor
0,025  0,020  Purinergic P2X agonist
0,017  0,012  Ileal bile acid transport inhibitor
0,012  0,007  Calcineurin inhibitor
0,047  0,042  mTOR inhibitor
0,082  0,078  Polo-like kinase-1 inhibitor
0,066  0,062  MAP3K7 inhibitor
0,020  0,016  Adenosine kinase inhibitor
0,059  0,055  Interferon inducer
0,017  0,014  Cyclin T1 inhibitor
0,185  0,181  Insulysin inhibitor
0,069  0,066  Keratolytic
0,025  0,022  Thymidine phosphorylase inhibitor
0,014  0,011  S-adenosyl-L-homocysteine hydrolase inhibitor
0,067  0,065  Orexin receptor 1 antagonist
0,012  0,010  Integrin beta2 antagonist
0,021  0,020  Adenosine A1 receptor agonist
0,071  0,069  Interferon agonist
0,045  0,044  Prolyl endopeptidase inhibitor
0,037  0,036  CF transmembrane conductance regulator antagonist
0,015  0,014  Nicotinic alpha4 receptor agonist
0,123  0,122  Male reproductive disfunction treatment
0,009  0,009  Purinergic P2Y2 agonist
0,017  0,017  Apical sodium codependent bile acid transporter inhibitor

